A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants

NCT06391827 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DA-7503 Single dose
DRUG: DA-7503 Multiple dose
DRUG: Placebo Single dose
DRUG: Placebo Multiple dose

Sponsor

Dong-A ST Co., Ltd.